.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Baxter
Johnson and Johnson
Merck
Cantor Fitzgerald
US Army
Deloitte
Queensland Health
Citi
UBS

Generated: September 20, 2017

DrugPatentWatch Database Preview

Sun Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?

SUN PHARM INDS has three hundred and seventy-eight approved drugs.

There are fourteen US patents protecting SUN PHARM INDS drugs and there have been two Paragraph IV challenges on SUN PHARM INDS drugs in the past three years. There are four tentative approvals on SUN PHARM INDS drugs.

There are fifty-five patent family members on SUN PHARM INDS drugs in thirty countries.

Summary for Applicant: Sun Pharm Inds

Patents:14
Tradenames:227
Ingredients:213
NDAs:378
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
TABLET;ORAL040480-005Sep 9, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL076911-002Sep 29, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
TRIMETHOPRIM
trimethoprim
TABLET;ORAL070494-001Jan 22, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL091118-001Sep 25, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
TABLET, CHEWABLE;ORAL065161-001Dec 3, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
TABLET;ORAL040863-001Dec 30, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
BACTRIM
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL017560-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
CHLORTHALIDONE
chlorthalidone
TABLET;ORAL089286-002Jul 21, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
TOPIRAMATE
topiramate
TABLET;ORAL076327-001Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL071078-001Nov 12, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Sun Pharm Inds

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds
BACTRIM
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL017560-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sun Pharm Inds Inc
EXELDERM
sulconazole nitrate
SOLUTION;TOPICAL018738-001Aug 30, 1985► Subscribe► Subscribe
Sun Pharm Inds
BACTRIM DS
sulfamethoxazole; trimethoprim
TABLET;ORAL017377-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sun Pharm Inds
BACTRIM
sulfamethoxazole; trimethoprim
TABLET;ORAL017377-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sun Pharm Inds
BACTRIM PEDIATRIC
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL017560-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sun Pharm Inds Ltd
ULTRAVATE
halobetasol propionate
CREAM;TOPICAL019967-001Dec 27, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SUN PHARM INDS drugs

Drugname Dosage Strength Tradename Submissiondate
isotretinoin
Capsules25 mg
ABSORICA
5/16/2016
isotretinoin
Capsules35 mg
ABSORICA
11/25/2015
isotretinoin
Capsules20 mg
ABSORICA
6/19/2013
isotretinoin
Capsules20 mg
ABSORICA
1/7/2013
isotretinoin
Capsules30 mg and 40 mg
ABSORICA
12/31/2012

Non-Orange Book Patents for Sun Pharm Inds

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,559,187 Liquid formulation of metformin► Subscribe
9,192,615Method for the treatment of acne and certain dosage forms thereof► Subscribe
8,722,650Extended-release minocycline dosage forms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Sun Pharm Inds Drugs

Country Document Number Estimated Expiration
Slovakia2102003► Subscribe
MexicoPA03001157► Subscribe
Israel154307► Subscribe
World Intellectual Property Organization (WIPO)2010017310► Subscribe
World Intellectual Property Organization (WIPO)2015094574► Subscribe
Canada2888853► Subscribe
Japan5744976► Subscribe
Japan2004505913► Subscribe
Hong Kong1214154► Subscribe
Eurasian Patent Organization201590730► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Sun Pharm Inds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0677Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121
2015000093Germany► SubscribePRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
00152Netherlands► SubscribePRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
C0028France► SubscribePRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124
C/GB96/053United Kingdom► SubscribePRODUCT NAME: DOXORUBICIN SULPHATE; REGISTERED: UK EU/1/96/011/001 19960621; UK EU/1/96/011/002 19960621
90013-1Sweden► SubscribePRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105
2014 00037Denmark► SubscribePRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116
90002Netherlands► SubscribePRODUCT NAME: CLOPIDOGREL WATERSTOFSULFAAT; REGISTRATION NO/DATE: EU 1/98/069/001 - EU 1/98/069/003 19980715
C0008Belgium► SubscribePRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208
2011005,C0984957Lithuania► SubscribePRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Fuji
Express Scripts
Chubb
Chinese Patent Office
McKesson
Accenture
McKinsey
Queensland Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot